Home›Stock Screener›Nirman Agri Genetics›Financial Statements

Nirman Agri Genetics Complete Financial Statements

6 Years of Data
2026 - 2021

In FYNone, Nirman Agri Genetics (NIRMAN) reported revenue ₹237 Cr, net profit ₹25 Cr and EPS ₹33.50, with a net profit margin of 9.1% and ROE of 14.1%. Full financial statements from FY2021 to FY2026 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Also explore NIRMAN share price data to track price trends across different timeframes.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 9.14% 2026 data
EBITDA Margin 9.64% 2026 data
Operating Margin 10.00% 2026 data
Return on Assets 13.95% 2026 data
Return on Equity 14.06% 2026 data

Balance Sheet Ratios

Equity Ratio 99.22% 2026 data
Asset Turnover 1.53 2026 data

NIRMAN Revenue, Net Profit & EBITDA — Year-on-Year Growth

NIRMAN YoY (March 2026 vs Period) — revenue +20.3%, net profit +38.9%, EBITDA +42.1%, expenses +18.0%. For live price, earnings ratios and company overview, see NIRMAN share price screener.

Revenue Growth
+20.3%
Year-over-Year
Net Profit Growth
+38.9%
Year-over-Year
EBITDA Growth
+42.1%
Year-over-Year
Expense Growth
+18.0%
Year-over-Year
Assets Growth
+14.2%
Year-over-Year
Equity Growth
+16.4%
Year-over-Year
Operating Cash Flow Growth
-900.0%
Year-over-Year
Investing Cash Flow Growth
+600.0%
Year-over-Year
Financing Cash Flow Growth
+4700.0%
Year-over-Year

NIRMAN Income Statement — Revenue, EBITDA & Net Profit

Nirman Agri Genetics revenue ₹237 Cr, EBITDA ₹27 Cr, net profit ₹25 Cr, EPS ₹33.50 (None) — net profit margin 9.1%. Analyse Nirman Agri Genetics ownership structure to track promoter, FII and institutional holdings.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022 March 2021
Revenue 237 197 237 63 29 14 4
Expenses 210 178 210 52 24 10 4
EBITDA 27 19 27 11 4 3 0
Operating Profit Margin % 11.00% 10.00% 11.00% 18.00% 15.00% 25.00% 2.00%
Depreciation 1 1 1 0 0 0 0
Interest 0 0 0 0 0 0 0
Profit Before Tax 26 18 26 11 4 3 0
Tax 1 1 1 1 0 1 0
Net Profit 25 18 25 10 4 3 0
Earnings Per Share (₹) 33.50 21.98 31.57 12.99 10.24 2560.20 54.70

NIRMAN Balance Sheet — Assets, Liabilities & Shareholders' Equity

NIRMAN total assets ₹129 Cr, total equity ₹128 Cr, total liabilities ₹ Cr (2026) — ROE 14.1%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021
ASSETS
Total Assets 129 113 44 30 6 2
Current Assets 118 101 22 9 6 2
Fixed Assets 2 2 0 1 0 0
Capital Work in Progress 0 0 0 0 0 0
Investments 47 0 0 0 0 0
Other Assets 0 111 44 29 6 2
LIABILITIES
Total Liabilities
Current Liabilities 0 0 0 1 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 128 110 37 27 3 0
Share Capital 8 8 6 6 0 0
Reserves & Surplus 120 102 31 21 3 0

NIRMAN Cash Flow Statement — Operating, Investing & Financing

Nirman Agri Genetics operating cash flow ₹-32 Cr, investing ₹10 Cr, financing ₹46 Cr, net cash flow ₹24 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021
Operating Activities -32 4 0 0 0
Investing Activities 10 -2 -21 0 0
Financing Activities 46 -1 20 0 1
Net Cash Flow 24 1 -1 0 1